Fred Pritchard, Ph.D.
About Fred Pritchard, Ph.D.
Fred Pritchard, Ph.D., serves as the Vice President of Drug Development Services at Celerion, where he has worked since 2010. With over 30 years of experience in the pharmaceutical industry, he specializes in drug development strategy and risk management.
Work at Celerion
Fred Pritchard, Ph.D., has been serving as the Vice President of Drug Development Services at Celerion since 2010. In this role, he oversees various aspects of drug development, leveraging his extensive experience in the pharmaceutical industry. His tenure at Celerion spans 14 years, during which he has contributed to the advancement of drug development strategies and risk management initiatives.
Previous Experience in Pharmaceutical Industry
Before joining Celerion, Fred Pritchard held several significant positions at GlaxoWellcome from 1988 to 2000. He served as the International Director of Business Strategy and Support, as well as Director of Clinical Pharmacology and Director Biomet. His career also includes a role as Section Head at Johnson & Johnson's McNeil Pharmaceutical from 1980 to 1988. Following his time at GlaxoWellcome, he worked at MDS Pharma Services as Vice President of Drug Development from 2000 to 2010.
Education and Expertise
Fred Pritchard earned his Ph.D. in Pharmacology from Penn State College of Medicine, where he studied from 1976 to 1979. He also holds an M.Sc. in Pharmacology and a B.Sc. (Hons) in Life Sciences from Queen's University. His expertise encompasses clinical pharmacology, drug metabolism, pharmacokinetics, and pharmacodynamics, with over 30 years of experience in drug development.
Achievements in Drug Development
Throughout his career, Fred Pritchard has been involved in nearly 40 integrated drug development programs and has successfully brought several drug development programs through Investigational New Drug (IND) applications into phase I and II clinical trials. He has worked on the pre-registration of five currently marketed pharmaceuticals and has authored over 120 scientific publications and abstracts.
Professional Affiliations and Contributions
Fred Pritchard has been active in various professional organizations. He served as the past Chair and Treasurer of the Research Triangle Park Drug Metabolism Discussion Group and is a member of the Executive Committee of the same group. Additionally, he serves on the Therapy Acceleration Program Committee for the Leukemia and Lymphoma Society and is a trustee of the LLS North Carolina Chapter Board.